SYN1 and epilepsy: The finding that epilepsy developed in 83% of SYN1 variant carriers published to date suggests that early molecular diagnosis of a SYN1 variant (for example, in children born within families known to carry a variant) should alert clinicians to the need for careful surveillance for possible seizures.